Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

US Global Nanospace Inc USGA

US Global Nanospace, Inc. (USGN) is a research and development company. The Company specializes in identifying, developing, and commercializing new and emerging technologies and products for integration into the security, defense and health and safety markets. USGN uses cross-discipline information in the areas of science, engineering, nanotechnology and nanomaterials to evolve products. The Company's products include MAPSANDS, All-Clear Chem/Bio Decontamination Foam, the G-Lam line of variable threat armor solutions, NanoFilters for Heating, ventilation, and air conditioning (HAVC), NanoFilterCX, BlastX and Radomes. MAPSANDS product is an autonomous, intelligent, fully integrated wide-area perimeter security and denial system. ALL-CLEAR product is a non-toxic decontaminant foam designed for the neutralization of chemical and biological weapons and contaminants. Blast-X is a lightweight blast mitigation material, including flat panels, conformable panels, and cast shapes.


GREY:USGA - Post by User

Post by Sarahhhon Apr 19, 2022 11:03pm
89 Views
Post# 34615353

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>